Estudo comparativo, randomizado. duplo-cego e cruzado da eficácia clínica e imunogenicidade das insulinas de origem suína e humana no tratamento de diabéticos tipo I

Leite, Silmar A. O; Costa, Paulo A. Bracarense; Réa, Rosângela R; Niclewicz, Edgard A.
Arq. bras. endocrinol. metab ; 37(1): 37-40, mar. 1993. tab, graf
Artículo en Portugués | LILACS | ID: lil-162705

Documentos relacionados

  1. Type 1 diabetes.
  2. Insulin requirements during lactation in women with diabetes mellitus type 1 in comparison with pre-pregnancy levels: A 10-year retrospective study.
  3. Habits related to the use of insulin infusion set in patients with type 1 diabetes on pump therapy - the effect of the educational intervention.
  4. Teplizumab: type 1 diabetes mellitus preventable?
  5. Provision of continuous subcutaneous insulin infusion to type 1 diabetes 'frequent flyers'.
  6. CELEBRATING 100 YEARS OF INSULIN USE.
  7. MHC-II heterozygosity limits type 1 diabetes susceptibility through negative selection.
  8. TCR<sup>+</sup>/BCR<sup>+</sup> dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes.
  9. Leveraging type 1 diabetes human genetic and genomic data in the T1D knowledge portal.
  10. Adaptive bolus calculators for people with type 1 diabetes: A systematic review.